Calcium signaling and molecular mechanisms underlying neurodegenerative diseases
- PMID: 28728834
- PMCID: PMC5748019
- DOI: 10.1016/j.ceca.2017.06.008
Calcium signaling and molecular mechanisms underlying neurodegenerative diseases
Abstract
Calcium (Ca2+) is a ubiquitous second messenger that regulates various activities in eukaryotic cells. Especially important role calcium plays in excitable cells. Neurons require extremely precise spatial-temporal control of calcium-dependent processes because they regulate such vital functions as synaptic plasticity. Recent evidence indicates that neuronal calcium signaling is abnormal in many of neurodegenerative disorders such as Alzheimer's disease (AD), Huntington's disease (HD) and Parkinson's disease (PD). These diseases represent a major medical, social, financial and scientific problem, but despite enormous research efforts, they are still incurable and only symptomatic relief drugs are available. Thus, new approaches and targets are needed. This review highlight neuronal calcium-signaling abnormalities in these diseases, with particular emphasis on the role of neuronal store-operated Ca2+ entry (SOCE) pathway and its potential relevance as a therapeutic target for treatment of neurodegeneration.
Keywords: Alzheimer disease; Ca(2+) homeostasis; Ca(2+) signaling; Huntington disease; Neurodegeneration; Neuronal store-operated Ca(2+) channels; Neuronal store-operated Ca2+ entry; Parkinson disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures
References
-
- Alzheimer's Association Calcium Hypothesis, W. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis. Alzheimers Dement. 2017;13:178–182 e117. - PubMed
-
- Arispe N, Diaz JC, Simakova O. Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers. Biochim Biophys Acta. 2007;1768:1952–1965. - PubMed
-
- Arshad A, Chen X, Cong Z, Qing H, Deng Y. TRPC1 protects dopaminergic SH-SY5Y cells from MPP+, salsolinol, and N-methyl-(R)-salsolinol-induced cytotoxicity. Acta Biochim Biophys Sin. 2014;46:22–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
